ELMMB logo
Facebook logo Twitter logo
Menu
13.0 Skin

13.0 Skin

13.2 Emollient and barrier preparations

Patient concordance and compliance with prescribed dermatology treatments is largely dependent on the cosmetic acceptability of the preparations concerned.  The dermatology section of the formulary contains a full range of suitable products to meet the needs of the vast majority of patients.

Fragrances are a major cause of skin sensitization, and as a general principle, products containing fragrance should not be prescribed. Patients insisting on using fragranced products should be advised to purchase their own supply. 

**NPSA Alert - Fire Hazard with Paraffin Based Skin Products on Dressings and Clothing

http://www.nrls.npsa.nhs.uk/resources/?entryid45=59876 

The National Patient Safety Agency (NPSA) is alerting all healthcare staff involved in the prescribing, dispensing or administration of paraffin based skin products of a potential fire hazard. Bandages, dressings and clothing in contact with paraffin based products, for example White Soft Paraffin, White Soft Paraffin plus Liquid Paraffin 50/50, or Emulsifying ointment are easily ignited with a naked flame or cigarette. Following a reported death, the NPSA commissioned the Health and Safety Executive to undertake fire hazard testing with White Soft Paraffin on a variety of bandages, dressings and clothing. The results showed the ability to reproduce the fire hazard in a controlled environment.

The following actions should apply to all patients in all settings being dispensed, or treated with, large quantities (100g or more) of paraffin based products:  

  • Information should be given about the potential fire risks of smoking (or being near to people who are smoking), or exposure to any open flame or other potential cause of ignition during treatment; and about regularly changing clothing or bedding impregnated with paraffin based products (preferably on a daily basis) as the paraffin soaks into the fabrics and can potentially be a fire hazard.
  • This information should be given on the first occasion that such treatment is prescribed, dispensed or administered by a healthcare professional and a record kept confirming that such advice has been given. A check should be made on subsequent occasions that the advice has been received previously and understood.
  • Fire safety information should be displayed prominently in every clinical area where patients may be treated with large quantities of paraffin based products.
  • If, against advice, a hospitalised patient intends to leave the ward to smoke, they should be informed of the risk and advised to wear a thick outer covering that has not been contaminated with paraffin based products.
  • Relatives or carers should be informed if a patient does not comply with safety advice.
  • To implement the NPSA alert, patients who require large quantities of emollient (100g or more) should use a water based product (e.g. cream or lotion) rather than a paraffin based one (e.g. ointment) to reduce the fire risk.

13.2.1 Emollients

Emollients are used to hydrate the skin. Their effects are short lived and they should be applied frequently. To be effective, adequate quantities of emollients should be prescribed. As a rough guide, 30g is sufficient for one total body application for an adult. Most adults could be expected to use 500-1000g of emollient each week (applying to whole body daily). 

Light emollients  
GREEN       Zerocream®       
GREEN      Cetraben® cream (pump pack)
GREEN      E45® cream
 
Medium emollients
GREEN      Epimax®  Cream 
GREEN      Zerobase® Cream 
GREEN      Zerobase® gel
GREEN      Aveeno® cream
GREEN      Diprobase® cream
GREEN      Doublebase® gel
GREEN      Oilatum® cream
GREEN      Unguentum® M cream
 
Heavy emollients - effective but not as cosmetically acceptable.
GREEN      Zeroderm® ointment 
GREEN      Hydromol® ointment 
GREEN      Epaderm® ointment (Consider using Hydromol - same formula, but less expensive)
GREEN      Liquid paraffin 50% / white soft paraffin 50% 
GREEN      Paraffin, white soft
GREEN      Paraffin, yellow soft
GREEN      Cetraben® ointment  
 
Containing urea 
GREEN      Eucerin® cream
 
With antimicrobial       
Appropriate for use if there are recurrent problems with infection.
GREEN      Dermol® cream
GREEN      Dermol 200® shower emollient
GREEN      Dermol 500® lotion
 
Soap substitutes 
All emollients, with the exceptions of Doublebase® and liquid paraffin, may be used as soap substitutes.  Aqueous cream may be used a soap substitute but is not recommended as an emollient because it may cause stinging  in a high proportion of patients.

GREEN      Aqueous cream (as a soap substitute only)
 

13.2.1.1 Emollient bath additives


GREEN      Hydromol Emollient® bath additive 
GREEN      Oilatum Plus® bath additive (contains antimicrobial agent)       

13.2.2 Barrier preparations 

Click here to access table of preparations and indications:      
First line:
GREEN      Metanium® ointment  
GREEN      Sudocrem® cream 
GREEN      Zinc and castor oil ointment    
GREEN      Medihoney® Barrier Cream 50g, 20 x 2g sachet  
GREEN      Sorbaderm®  No-sting Barrier Film 28ml spray, 1ml applicator    
 
Second line, following Specialist Advice:
GREEN      Proshield® Foam and Spray Cleanser 235ml 
GREEN      Proshield® Plus Skin Protective 115g       
 
 13.3 Topical local anaesthetics and antipuritics
The underlying cause of the pruritus should be treated. Antipruritics are of limited value.
GREEN       Crotamiton cream 10%, lotion 10% (Eurax®)     
GREEN       Menthol 1% in aqueous cream 500gram (Arjun®)   
 
Facilitation of wound care, cleaning and suturing in A&E only 
RED            Lidocaine 4%, adrenaline 0.1%, tetracaine 0.5% w/v gel (LAT gel®)
                   (Unlicensed product. Approved for use in A&E Department only)  


 13.4 Topical corticosteroids

Potency of steroid required will depend on age, site and chronicity. Face, flexures, skin of the young and more acute eczemas require weaker preparations. Palms, soles and heavily lichenified chronic eczemas require more potent preparations. Try to use the weakest preparation which will keep the eczema in check, but if control is lost, use a short, sharp course of a potent preparation. 

Creams are best for wet and weepy lesions.
Ointments are best for dry and scaly lesions.
 
POTENCY – MILD 
First line:   
GREEN        Hydrocortisone cream 0.5%, 1%, 2.5% , ointment 0.5%, 1%, 2.5% 
GREEN       Hydrocortisone cream 0.25% & crotamiton 10% (Eurax-Hydrocortisone®)       
 
Second line:    
GREEN      Fluocinolone 0.0025%cream (Synalar 1 in 10 Dilution®)  
                  (for patients intolerant to hydrocortisone) 
 
POTENCY - MILD WITH ANTIMICROBIAL 
GREEN      Hydrocortisone 1% & miconazole 2% cream, ointment (Daktacort®)   
GREEN      Hydrocortisone 0.5% & nystatin 100,000 units/g cream (Timodine®)       
 
POTENCY – MODERATE
First line:   
GREEN      Clobetasone butyrate 0.05% cream, ointment (Eumovate®) 

Second line:
GREEN      Betamethasone valerate 0.025% cream, ointment (Betnovate RD®)     
GREEN      Fluocinolone 0.00625% cream, ointment (Synalar 1 in 4 Dilution®)       
GREEN      Fludroxycortide occlusive tape 4micrograms/cm2 (Haelan®)  -   (Dermatology initiation only)  
 
POTENCY – MODERATE WITH ANTIMICROBIAL 
GREEN      Clobetasone butyrate 0.05% & oxytetracycline/®nystatin cream (Trimovate®)
** product currently unavailable from manufacturer (03/15) - see below for alternative**
 
POTENCY - POTENT 
First line:
GREEN      Betamethasone valerate 0.1% cream, ointment (Betnovate®)  
 
Second line: 
GREEN      Fluocinolone 0.025% cream, ointment (Synalar®) 
AMBER     Mometasone furoate 0.1% cream, ointment, lotion (Elocon®)                                                                                                           (Dermatology initiation only)    
AMBER     Diflucortolone valerate 0.1%                                                                                                                                                                   cream, oily cream, ointment (Nerisone®)  

Scalp preparations
First line:

GREEN      Betamethasone valerate scalp application 0.1% (Betacap®)

Second line:
GREEN      Fluocinolone 0.025% gel (Synalar®)
GREEN      Hydrocortisone butyrate 0.1% water miscible lotion (Locoid Crelo®)
 
POTENCY – POTENT WITH ANTIMICROBIAL 
GREEN      Betamethasone dipropionate 0.064% (≡ betamethasone 0.05%), clotrimazole 1%, cream (Lotriderm®)** 
GREEN      Fluocinolone acetonide 0.025% & Clioquinol 3% cream,ointment  (Synalar C®)     
GREEN      Fluocinolone 0.025% & neomycin 0.5% cream, ointment (Synalar N®)    (For Otitis Externa only)
 
POTENCY - POTENT WITH SALICYLIC ACID 
GREEN      Betamethasone valerate 0.05% & salicylic acid 3% ointment (Diprosalic®)      
 
POTENCY - VERY POTENT 
Avoid long-term use without dermatologist supervision
GREEN      Clobetasol 0.05%
                  cream, ointment (Dermovate®)    
                  scalp application (Dermovate®)   
GREEN      Diflucortolone valerate 0.3% 
                   oily cream, ointment (Nerisone Forte®)    

AMBER     Clobetasol propionate 500micrograms/gram shampoo (Etrivex®) 

Clobetasol Propionate shampoo - Scalp Psoriasis
Clobetasol shampoo should be kept in place without covering for 15 minutes before rinsing. The treatment duration should be limited to a maximum of 4 weeks. As soon as clinical results are observed, applications should be spaced out or replaced, if needed, by an alternative treatment. If no improvement is seen within four weeks, reassessment of the diagnosis may be necessary. Repeated courses may be used to control exacerbations provided the patient is under regular medical supervision.
 
POTENCY – VERY POTENT WITH ANTIMICROBIAL
Avoid long-term use without dermatologist supervision
GREEN      Clobetasol 0.05% & neomycin/nystatin cream, ointment
                  (Dermovate-NN® brand discontinued prescribe as  generic)    

3.5.1 Preparations for eczema

Oral retinoids for severe hand eczema

Alitretinoin, for the treatment of Chronic Eczema (TAG 177)                                                                                                        Alitretinoin is recommended, within its licensed indication, as a treatment option for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids if the persons has 

  • severe disease, as defined by the physician’s global assessment (PGA) and    
  • a dermatology life quality index (DLQI) score of 15 or more.  

Oral alitretinoin is licensed for the treatment of severe chronic hand eczema unresponsive to potent topical corticosteroids, in adults. Alitretinoin should only be prescribed by dermatologists, or physicians with experience in the use of systemic retinoids who have full understanding of the risks of systemic retinoid therapy and monitoring requirements. Prescriptions of alitretinoin for women of childbearing potential should be limited to 30 days of treatment and continuation of treatment requires a new prescription. Ideally, pregnancy testing, issuing a prescription and dispensing of alitretinoin should occur on the same day. 

Dispensing of alitretinoin should occur within a maximum of 7 days of the prescription. Pregnancy is an absolute contraindication to treatment with alitretinoin. Basilea Pharmaceuticals has put together a Pregnancy Prevention Programme, containing guidance on prescribing alitretinoin to women of childbearing potential and contraceptive precautions required. A treatment course of alitretinoin may be given for 12 to 24 weeks depending on response. Discontinuation of therapy should be considered for patients who still have severe disease after the initial 12 weeks of treatment. In the event of relapse, patients may benefit from further treatment courses of alitretinoin. Patients should still be advised to use daily emollients during therapy and once the eczema has cleared.  

RED           Altretinoin (Toctino®) capsules 10mg, 30mg 

13.5.2 Preparations for psoriasis

Emollients may be sufficient for mild cases. For other cases the topical preparations may have a beneficial effect. Start with low concentrations and build up.

Topical preparations for psoriasis

Vitamin D and analogues
GREEN      Calcipotriol 50micrograms/gram (Dovonex®)    
                  cream, ointment, scalp solution 
GREEN      Calcipotriol 50 micrograms/gram & betamethasone 0.05% (Dovobet®) 
                  ointment, gel   
GREEN      Tacalcitol 4 micrograms/gram (Curatoderm®)  ointment
GREEN      Calcipotriol and betamethasone cutaneous foam (Enstilar®)                    
 
Coal tar 
GREEN      Licensed Coal tar products:  
                  lotion 5%  (Exorex®)                                                                                                                                                                                   scalp ointment, coal tar 12% & salicylic acid 2%, sulphur 4% (Sebco®)                                                                                           bath emulsion 40% (Psoriderm®)           
AMBER     Unlicensed Coal tar products Dermatology initiation only                                                                                                                  e.g. coal tar in yellow soft paraffin, various strengths       
 
Dithranol 
For other dithranol preparations see appendix 3. 
GREEN      Dithranol (Dithrocream®) cream 0.1%, 0.25%, 0.5%, 1%, 2%      
AMBER     Dithranol in Lassar's paste (unlicensed product)
                  (dermatology initiation only) various strengths  
 
Oral retinoids for psoriasis - for severe resistant or complicated psoriasis, prescribed only by or under the supervision of a consultant dermatologist. 
RED           Acitretin capsules 10mg, 25mg (hospital only)  

13.5.3 Drugs affecting the immune response
CSM Advice – Due to the risk of malignancy, Pimecrolimus 1% cream should be used as a second line treatment for 
mild or moderate atopic dermatitis where treatment with topical corticosteroids is either inadvisable or not possible. 
Tacrolimus ointment will remain a second line treatment for moderate or severe atopic dermatitis in patients who are
not adequately responsive to or are intolerant of topical corticosteroids. 
 
Treatment with pimecrolimus cream and tacrolimus ointment should:  
  • only be initiated by physicians with experience in the diagnosis and treatment of atopic dermatitis
  • not to be given to patients with congenital or acquired immunodeficiencies, or to patients on therapy causing immunosupprerssion
  • not to be applied to malignant or to potentially malignant skin lesions.
The frequency of administration of Tacrolimus ointment 0.03% in children should be limited to once daily. The lower strength of tacrolimus ointment (0.03%), should be used in adults wherever possible.
 
Prescribers should use these products so as to minimise patient exposure and thereby reduce risk.  The following are recommended:   
       >    The medicines should be applied thinly and to affected skin surfaces only.
       >    Treatment should be short term; continuous longterm use should be avoided.
       >    If no improvement occurs (after 6 weeks for pimecroliums, or 2 weeks for tacrolimus), or if the disease 
             worsens, the diagnosis of atopic dermatitis should be reevaluated and other therapeutic options 
             considered. See age restrictions for each product before prescribing.
 
NICE Guidance: Atopic Eczema in Children
       >    Only specialists with experience in dermatology should start treatment with tacrolimus or pimecrolimus after
             discussing the risks and benefits of all other options.
       >    If atopic eczema is not controlled by topical corticosteroids* or where there is a risk of serious adverse effects
             treatment options include:
                     >      tacrolimus (0.03%) for moderate to severe atopic eczema in children aged two years and over,
                     >      pimecrolimus for moderate atopic eczema on the face and neck in children aged two years and over.
       >    Consider for facial atopic eczema in children requiring long-term or frequent use of mild topical corticosteroids           >    Do not use topical tacrolimus or pimecrolimus:       
                     >      for mild atopic eczema,
                     >      as first-line treatment for atopic eczema of any severity,
                     >      under bandages or dressings without specialist dermatological advice.
 
 *Unsatisfactory clinical response to adequate use of the maximum strength and potency of topical corticosteroids that is appropriate for the child's age and the area being treated.

Active plaque psoriasis in adults 
Ustekinumab is recommended as an option, alone or in combination with methotrexate, for treating active plaque psoriasis in adults as per NICE  TA340  (replaces TA313)

RED      Ustekinumab 
             solution for injection 45mg/0.5ml pfs (Stelara®)                                             (CCG Commissioned)          

Moderate to severe psoriasis    NICE TA180  (updated)
NICE interactive flowchart - Psoriasis
Ustekinumab
is recommended as a treatment option for adults with plaque psoriasis as in NICE TA180 updated

RED      Ustekinumab 
             solution for injection 45mg/0.5ml pfs (Stelara®)                                             (CCG Commissioned)           

13.6.1 Topical preparations for acne

For mild and moderate acne a topical preparation is recommended.
Benzoyl peroxide & azelaic acid
Patients should be advised that, in some cases, 4-6 weeks of treatment may  be required before the full therapeutic effect is observed.
GREEN      Benzoyl peroxide (PanOxyl®) cream 5% & gel 10% (if available)     
GREEN      Duac Once Daily®  (Benzyl peroxide 5% & clindamycin 1%) gel 
GREEN      Azelaic acid (Skinoren®) cream 20% 
 
Topical antibacterials for acne
GREEN      Dalacin T® aqueous lotion (clindamycin 1%)       
GREEN      Zineryt® topical solution (erythromycin 40mg & zinc acetate 12mg/ml)  
 
Topical retinoids and related preparations for acne
GREEN      Adapalene (Differin®) cream 0.1%, gel 0.1%
GREEN      Isotretinoin (Isotrex®)  gel 0.05% 
GREEN      Adapalene 0.1%/Benzoyl Peroxide 2.5% (Epiduo®Gel) 
GREEN      Tretinoin and clindamycin (Treclin®) 1%/0.025% gel      
 
Preparations for rosacea
GREEN      Metronidazole (Rosex®) cream 0.75%
GREEN      Ivermectin (Soolantra®) cream 


13.6.2 Oral preparations for acne 


Oral antibacterials for acne
For moderate acne oral antibiotics are usually needed and should be prescribed alongside a topical retinoid or benzoyl peroxide. Oral antibiotics should be limited to the shortest possible period.
If the patient responds it may be continued for 4-6 months. (consider reducing the antibiotic dose by half for the latter period ) then stop completely. 
 
First line
GREEN        Tetracycline tablets 250mg (dose: 500mg twice daily)
GREEN       Oxytetracycline tablets 250mg (dose: 500mg twice daily)
 
For use in cases where first line drugs are not tolerated or ineffective
GREEN      Doxycycline capsules 100mg (dose: 100mg  daily)
GREEN      Lymecycline capsules 408mg (dose: 408mg daily)


Hormone treatment for acne
Used as an alternative to oral antibiotics for female patients. 
Co-cyprindiol (Dianette®) - used primarily as a treatment for moderate acne or other androgenic conditions especially hirsutism (e.g in patients with PCOS) who also need contraception. It should be discontinued three to four months after the androgenic condition has resolved.   It may be continued/restarted, after counselling, if the androgenic condition recurs. It should not be used solely for contraception. 
 
Note: CSM advice is venous thromboembolism occurs  more frequently in women taking co-cyprindiol than those taking a low-dose combined oral contraceptive. See BNF for full details. 
 
GREEN       Co-cyprindiol tablets (cyproterone 2mg & ethinylestradiol 35mcg)   
                     (Prescribe generically, not as Dianette®)
 
Oral retinoid for acne

For severe acne which has not responded to oral antibiotics, prescribed only by or under the supervision of a consultant dermatologist.

RED           Isotretinoin capsules 5mg, 20mg        

 13.7 Preparations for warts and calluses

All warts are self-limiting and eventually disappear spontaneously. Salicyclic acid preparations are useful but may cause irritation of the treated area.
 
First line 
GREEN      Salactol® paint (contains salicylic acid 16.7%, lactic acid 16.7% in colloidon)
 
Second line
GREEN      Salicylic acid 50% ointment (Verrugon®)
GREEN      Salicylic acid 26% polyacrylic solution (Occlusal®)
 
Third line
GREEN      Formaldehyde 0.75% gel (Veracur®)
GREEN      Glutaraldehyde 10% solution (Glutarol®)
 
Anogenital warts 
Imiquimod cream is also licensed for the treatment of superficial basal cell carcinomas and is also used for actinic keratoses (unlicensed and specialist use only).
 
GREEN      Podophyllotoxin    0.15% cream (Warticon®) 
GREEN      Imiquimod 5% cream (Aldara®)

13 8.1 Sunscreen preparations

All the sunscreens listed contain UVB and UVA protection. They are drugs when prescribed for skin protection against ultraviolet radiation in abnormal cutaneous photosensitivity. Need to be endorsed 'ACBS' on FP10 prescription. 
 
GREEN      Anthelios® melt in cream (UVA + UVB protection UVB-SPF 50+)          
GREEN      Sunsense®  Ultra Lotion (UVA +UVB protection UVB-SPF 50+)
GREEN      Uvistat®cream (UVB-SPF 20) 
 
Sunscreen/ camouflagers
A combination product suitable for patients with darker skin tones which is available from Dundee Hospital only.
RED            Dundee Cream (UVB-SPF 50)  
 
Photodamage 
GREEN      Diclofenac sodium 3% gel (Solaraze®) - prescribe by brand
AMBER      Fluorouracil 5% cream (Efudix®) 
 
 

13 8.2  Hirsutism 


BLACK            Eflornithine (Vaniqa ® 11.5% cream) 

13.9 SHAMPOOS AND SOME OTHER PREPARATIONS FOR SCALP AND HAIR CONDITIONS

GREEN      AlphosyI 2 in 1® shampoo 
GREEN      Capasal® shampoo     
GREEN      Polytar® liquid
GREEN      Selsun® shampoo 
 
Other scalp preparations see
13.4     Clobetasol propionate 500micrograms/gram shampoo  (Etrivex®)
 
13.5.2  Calcipotriol/ betamethasone scalp application  (Dovobet®) 

 

13.10.1 Antibacterial preparations 

13.10.1.1 Antibacterial preparations only used topically
To reduce the development of resistance it is advisable to limit the choice of antibiotic used topically to one not used systemically. Whenever possible, swabs for bacterial examination should be taken before treatment is started. Mupirocin is generally restricted to use in wounds that are MRSA positive. 
 
GREEN      Mupirocin 2% (Bactroban®) ointment / nasal ointment   
GREEN      Silver sulphadiazine 1% (Flamazine®) cream  

13.10.1.2.2 Preparations of antibacterials also used systemically

It is generally advised that topical antimicrobials are not used.  The exceptions to this are the use of metronidazole topically for acne rosacea, and in the management of malodorous wounds.  Topical fusidic acid should be reserved for impetigo where there are very localised lesions only. 
In the presence of visible or proven infection, systemic antibiotics are to be used.  See antimicrobial guidelines.
 
GREEN      Fusidic acid 2% (Fucidin®) cream, ointment [see recommendations above] 
GREEN      Metronidazole (Anabact®) 0.75% gel  [see recommendations above] 


13.10.2 Antifungal preparations

Take scrapings, hair or nail clippings where possible before treatment is started. Local therapy is used when extent of infection is limited. Systemic therapy is required for widespread infections, or if topical treatment fails.  If treating pityriasis vesicolor and topical treatment fails, treat systemically with an azole antifungal (section 5.2). 
 
GREEN      Clotrimazole  cream 1%,  dusting powder 1%        
GREEN      Miconazole cream 2%           
GREEN      Terbinafine cream 1%          
 
For infected nails
GREEN     Amorolfine nail lacquer 5% (Loceryl®)
 
Other antifungals (for azole antifungals see section 5.2) 
GREEN      Terbinafine tablets 250mg       
 

13.10.3 Antiviral preparations

Indicated for treatment of labial and genital herpes simplex infections.
GREEN     Aciclovir cream 5% 


13.10.4 Parasiticidal preparations

Head lice
Only treat those with living, moving lice present.  A course of treatment for head lice should be 2 applications of product 7 days apart to kill the lice emerging from any eggs that survive the first application. All affected household members should be treated simultaneously. 
 
Wet Combing
Head lice can be mechanically removed by combing wet hair meticulously with a plastic detection comb for at least 30 minutes over the whole scalp at 4-day intervals for a minimum of 2 weeks, and continued until no lice are found on 3 consecutive sessions. 
 
Dimeticone
Hedrin (4% dimeticone) lotion is a non-insecticide preparation that coats head lice and interferes with water balance in lice by preventing the excretion of water.  It can be used from age 6 months, and has shown similar efficacy to phenothrin 0.5% liquid (70% vs. 75% cure rate).  As with the other insecticide treatments this is a pharmacy only medicine and treatment should follow the same regime as is laid out for those other products i.e. treatment is 2 applications 7 days apart. The contact time for this product is 8 hours or overnight.  One 50ml bottle should be sufficient for two applications on short hair.
 
Refer to guidelines online here
 
First (or Second) Line
GREEN       Dimeticone lotion 4%, aqueous          
 
First (or Second) Line
Use alcohol based preparations where possible.  Use aqueous liquid for those with asthma and severe eczema, children under 5 years and pregnant & lactating women.
GREEN      Malathion liquid 0.5%, aqueous       
GREEN      Malathion lotion 0.5%, alcoholic        
 
Crab Lice
Permethrin or malathion are used to eliminate crab lice. An aqueous preparation should be applied, allowed to dry naturally and washed off after 12 hours. A second treatment will be needed after 7 days. 
 
Scabies
Permethrin is effective for scabies.  
GREEN        Permethrin cream 5%


13.11.1 Alcohols and saline

Suitable for general cleansing of skin and wounds.  
See Joint Wound Care Formulary for order of preference - click here to access it
GREEN     Sodium chloride 0.9% solution sachets (Irripod®, Normasol®)


13.11.2 Chlorhexidine salts

Suitable for disinfection of skin.
GREEN     Chlorhexidine cleansing solution (Hibiscrub®)
GREEN     Chlorhexidines Gluconate Alcoholic & Aqueous Solutions (Hydrex® & Unisept® respectively)
 
 Both products are for skin disinfection by primary care prescribers only (different preparations are routinely                      used in secondary care). Both are listed on the Nurse Practitioners Formulary.
 

13.11.4 Iodine

Suitable for disinfection of skin
GREEN       Povidone-iodine (Betadine®)
                    antiseptic paint 10%,  antiseptic solution 10%, dry powder spray 2.5%,  surgical scrub 7.5%

                  

13.11.5 Phenolics

Used as part of MRSA regimen
GREEN     Octenisan® skin cleanser  
GREEN     Triclosan skin cleanser


13.11.6 Astringents, oxidisers and dyes

Useful for oozing eczematous reactions
GREEN       Hydrogen peroxide solution 3% (10 vols.)
GREEN       Potassium permanganate 400mg tablets for solution (Permitabs®)
                       - 1 tablet dissolved in 4 litres in water provides a 0.01% (1 in 10,000) solution 

A potent antiperspirant used in the treatment of severe hyperhidrosis 

GREEN       Aluminium chloride 20% solution (Anhydrol Forte®)

AMBER      Glycopyrronium Bromide powder (Robinul®)